Abstract: In certain embodiments, a system includes a frame with top, middle, and bottom sections. The system further includes a first roller section coupled to the frame and positioned at the top section of the frame. A second roller section is coupled to the frame and positioned at the middle section of the frame. One of the first and second roller sections includes a battery, wireless receiver, motor, and optical sensor.

Abstract: In certain embodiments, a system includes a frame with top, middle, and bottom sections. The system further includes a first roller section coupled to the frame and positioned at the top section of the frame. A second roller section is coupled to the frame and positioned at the middle section of the frame. One of the first and second roller sections includes a battery, wireless receiver, motor, and optical sensor.

Abstract: The invention provides polypeptides containing ?-MSH that can be used to treat diseases characterized by inflammation and/or autoimmunity. Also included in the invention are ?-MSH analogs and nucleic acids encoding polypeptides containing ?-MSH and ?-MSH analogs optionally linked to heterologous sequences. Also included in the invention are methods of delivering ?-MSH containing peptides, ?-MSH analogs, an DNA encoding ?-MSH and ?-MSH analogs.

Abstract: The invention includes methods of treating an HPV-mediated disease by administration to an individual of a pharmaceutical composition comprising a nucleic acid that encodes a polypeptide comprising an epitope of a naturally occurring HPV protein. The methods include the selection of individuals for treatment with the composition according to the age of the recipient, as well as the use of the composition to elicit a cross-reactive anti-HPV immune response.

Abstract: The invention provides polypeptides containing ?-MSH that can be used to treat diseases characterized by inflammation and/or autoimmunity. Also included in the invention are ?-MSH analogs and nucleic acids encoding polypeptides containing ?-MSH and ?-MSH analogs optionally linked to heterologous sequences. Also included in the invention are methods of delivering ?-MSH containing peptides, ?-MSH analogs, an DNA encoding ?-MSH and ?-MSH analogs.

Abstract: The invention provides nucleic acids encoding polyepitope polypeptides containing multiple epitopes from one or more proteins. The polyepitope polypeptides are useful as treatments for pathogenic agents or tumors.

Abstract: An exemplary power management system may include a power source and a transmission. The transmission may include a drive member and at least two shift ranges. The drive member may be driveably engaged with the power source. The power management system may also include a control system in communication with the power source and the transmission. The control system may be operative to cause a shift transition between the at least two shift ranges in response to a shift command. The control system may also be operative, during at least a portion of the shift transition, to modify at least one of a speed of the drive member and a speed of the power source based on at least one of a load condition of the power source, a speed of the power source, and the at least two shift ranges.

Abstract: An exemplary power management system may include a power source and a transmission. The transmission may include a drive member and at least two shift ranges. The drive member may be driveably engaged with the power source. The power management system may also include a control system in communication with the power source and the transmission. The control system may be operative to cause a shift transition between the at least two shift ranges in response to a shift command. The control system may also be operative, during at least a portion of the shift transition, to modify at least one of a speed of the drive member and a speed of the power source based on at least one of a load condition of the power source, a speed of the power source, and the at least two shift ranges.